Cargando…
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation.
We have studied the pharmacokinetics of mitoxantrone in cancer patients. Two regimens were used: eight women (10 kinetics) received a 10 min i.v. infusion of 12 mg m-2 of mitoxantrone; seven women (seven kinetics) received high-dose mitoxantrone associated to high-dose alkylating agents and underwen...
Autores principales: | Richard, B., Launay-Iliadis, M. C., Iliadis, A., Just-Landi, S., Blaise, D., Stoppa, A. M., Viens, P., Gaspard, M. H., Maraninchi, D., Cano, J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977616/ https://www.ncbi.nlm.nih.gov/pubmed/1558794 |
Ejemplares similares
-
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.
por: Philip, T., et al.
Publicado: (1986) -
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule.
por: Ballestrero, A., et al.
Publicado: (1997) -
Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice.
por: Rentsch, K. M., et al.
Publicado: (1997) -
A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
por: Launay, M. C., et al.
Publicado: (1989) -
Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes
por: Zhuang, Jie, et al.
Publicado: (2010)